| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
| mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.006 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.007 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.008 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.009 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |